{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:51:05Z","timestamp":1792155065235,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Theory Biosci."],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Field cancerization, the process wherein prior insults corrupt the semiotic landscape through which immune cells detect and respond to \u201cthe other\u201d, persists even after the precipitating conditions resolve and the tissue histologically appears normal. This exemplifies a broader explanatory problem: How can we account for biomedical phenomena whose pathology is constituted by a history that standard mechanistic accounts cannot recover? I argue that a comprehensive understanding of field cancerization requires us to supplement molecular mechanistic explanations with lineage-level accounts, developed through a dialogue among Derrida\u2019s hauntology, ghost criminology, and von Uexk\u00fcll\u2019s\n                    <jats:italic>Umwelt<\/jats:italic>\n                    as formalized through Peirce\u2019s triadic model of signs. This framework generates a three-ghost taxonomy of immune semiotic corruption, explains why treating the present condition without addressing historically constituted corruption fails, and suggests concrete therapeutic implications based on this framework.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Keywords<\/jats:bold>\n                    : field cancerization, immunology, biosemiotics, hauntology, ghost criminology,\n                    <jats:italic>Umwelt<\/jats:italic>\n                    , Derrida, Peirce\n                  <\/jats:p>","DOI":"10.1007\/s12064-026-00496-5","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:11:00Z","timestamp":1792152660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The haunted Umwelt: a biosemiotic and hauntological account of immune semiotic corruption in field cancerization"],"prefix":"10.1007","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-626X","authenticated-orcid":false,"given":"Anuraag","family":"Bukkuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"496_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.livres.2024.05.004","volume":"8","author":"W Abdelhamed","year":"2024","unstructured":"Abdelhamed W, El-Kassas M (2024) Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do. Liver Res 8:83\u201390. https:\/\/doi.org\/10.1016\/j.livres.2024.05.004","journal-title":"Liver Res"},{"key":"496_CR2","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","volume":"65","author":"S Armeanu","year":"2005","unstructured":"Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR (2005) Natural Killer Cell\u2013Mediated Lysis of Hepatoma Cells via Specific Induction of NKG2D Ligands by the Histone Deacetylase Inhibitor Sodium Valproate. Cancer Res 65:6321\u20136329. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4252","journal-title":"Cancer Res"},{"key":"496_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/jgid.jgid_211_23","volume":"16","author":"AA Awadh","year":"2024","unstructured":"Awadh AA, Alharthi AA, Alghamdi BA, Alghamdi ST, Baqays MK, Binrabaa IS, Malli IA (2024) Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis. J Glob Infect Dis 16:127\u2013134. https:\/\/doi.org\/10.4103\/jgid.jgid_211_23","journal-title":"J Glob Infect Dis"},{"key":"496_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/1-4020-4814-9","volume-title":"Introduction to Biosemiotics: The New Biological Synthesis","year":"2007","unstructured":"Barbieri M (ed) (2007) Introduction to Biosemiotics: The New Biological Synthesis. Springer Netherlands, Dordrecht. https:\/\/doi.org\/10.1007\/1-4020-4814-9"},{"key":"496_CR5","volume-title":"Elements of semiology, 34. [print]","author":"R Barthes","year":"1977","unstructured":"Barthes R, Barthes R (1977) Elements of semiology, 34. [print]. ed. Hill and Wang, New York, NY"},{"key":"496_CR6","volume-title":"Mythologies, 47. [print]","author":"R Barthes","year":"2006","unstructured":"Barthes R, Lavers A, Barthes R (2006) Mythologies, 47. [print]. ed. Hill and Wang, New York, NY"},{"key":"496_CR7","first-page":"1727","volume":"63","author":"BJM Braakhuis","year":"2003","unstructured":"Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of slaughter\u2019s concept of field cancerization: Evidence and clinical implications. Cancer Res 63:1727\u20131730","journal-title":"Cancer Res"},{"key":"496_CR8","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3934\/mbe.2026097","volume":"23","author":"A Bukkuri","year":"2026","unstructured":"Bukkuri A (2026) Hauntings in the field: The evolutionary dynamics of semiotic corruption and tissue normativity in carcinogenesis. Math Biosci Eng 23:2698\u20132719. https:\/\/doi.org\/10.3934\/mbe.2026097","journal-title":"Math Biosci Eng"},{"key":"496_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fevo.2021.678533","volume":"9","author":"A Bukkuri","year":"2021","unstructured":"Bukkuri A, Adler F (2021) Viewing cancer through the lens of corruption: using behavioral ecology to understand cancer. Front Ecol Evol 9:1\u201314","journal-title":"Front Ecol Evol"},{"key":"496_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/emph\/eoad017","volume":"11","author":"A Bukkuri","year":"2023","unstructured":"Bukkuri A, Adler F (2023) Biomarkers or biotargets? using competition to lure cancer cells into evolutionary traps. Evol Med Public Health 11:264\u2013276","journal-title":"Evol Med Public Health"},{"key":"496_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cdev.2024.203964","volume":"180","author":"A Bukkuri","year":"2024","unstructured":"Bukkuri A, Adler FR (2024) Of criminals and cancer: the importance of social bonds and innate morality on cellular societies. Cells Dev 180:1\u20136. https:\/\/doi.org\/10.1016\/j.cdev.2024.203964","journal-title":"Cells Dev"},{"key":"496_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1\u201317. https:\/\/doi.org\/10.1128\/CMR.16.1.1-17.2003","journal-title":"Clin Microbiol Rev"},{"key":"496_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.ajpath.2013.01.009","volume":"182","author":"JS Byun","year":"2013","unstructured":"Byun JS, Gardner K (2013) Wounds that will not heal: pervasive cellular reprogramming in cancer. Am J Pathol 182:1055\u20131064. https:\/\/doi.org\/10.1016\/j.ajpath.2013.01.009","journal-title":"Am J Pathol"},{"key":"496_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/bjps\/axn047","volume":"60","author":"B Calcott","year":"2009","unstructured":"Calcott B (2009) Lineage explanations: explaining how biological mechanisms change. Br J Philos Sci 60:51\u201378. https:\/\/doi.org\/10.1093\/bjps\/axn047","journal-title":"Br J Philos Sci"},{"key":"496_CR15","volume-title":"Radical hermeneutics: repetition, deconstruction, and the hermeneutic project, Studies in phenomenology and existential philosophy","author":"JD Caputo","year":"1987","unstructured":"Caputo JD (1987) Radical hermeneutics: repetition, deconstruction, and the hermeneutic project, Studies in phenomenology and existential philosophy. Indiana University Press, Bloomington, Ind"},{"key":"496_CR16","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","volume":"162","author":"KB Chiappinelli","year":"2015","unstructured":"Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A, Makarov V, Buhu S, Slamon DJ, Wolchok JD, Pardoll DM, Beckmann MW, Zahnow CA, Merghoub T, Chan TA, Baylin SB, Strick R (2015) Inhibiting DNA methylation causes an interferon response in cancer via dsRNA. Including Endogenous Retroviruses Cell 162:974\u2013986. https:\/\/doi.org\/10.1016\/j.cell.2015.07.011","journal-title":"Including Endogenous Retroviruses Cell"},{"key":"496_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/pathogens12020298","volume":"12","author":"S Choi","year":"2023","unstructured":"Choi S, Ismail A, Pappas-Gogos G, Boussios S (2023) HPV and cervical cancer: a review of epidemiology and screening uptake in the UK. Pathogens 12:298. https:\/\/doi.org\/10.3390\/pathogens12020298","journal-title":"Pathogens"},{"key":"496_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.102","author":"K Curtius","year":"2017","unstructured":"Curtius K, Wright NA, Graham TA (2017) An evolutionary perspective on field cancerization. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/nrc.2017.102","journal-title":"Nat Rev Cancer"},{"key":"496_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-7-2","author":"GD Dakubo","year":"2007","unstructured":"Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL (2007) Clinical implications and utility of field cancerization. Cancer Cell Int. 7https:\/\/doi.org\/10.1186\/1475-2867-7-2","journal-title":"Cancer Cell Int"},{"key":"496_CR21","volume-title":"Dissemination","author":"J Derrida","year":"1983","unstructured":"Derrida J (1983) Dissemination. Univ. of Chicago Press, Chicago, Illinois"},{"key":"496_CR20","volume-title":"Specters of Marx: the state of the debt, the work of mourning, and the New international","author":"J Derrida","year":"1994","unstructured":"Derrida J (1994) Specters of Marx: the state of the debt, the work of mourning, and the New international. Routledge, New York"},{"key":"496_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coi.2018.02.004","volume":"51","author":"P Dhar","year":"2018","unstructured":"Dhar P, Wu JD (2018) NKG2D and its ligands in cancer. Curr Opin Immunol 51:55\u201361. https:\/\/doi.org\/10.1016\/j.coi.2018.02.004","journal-title":"Curr Opin Immunol"},{"key":"496_CR23","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy K, Colbert JD, Rock KL (2021) Cancer immune evasion through loss of mHC class I antigen presentation. Front Immunol 12:636568. https:\/\/doi.org\/10.3389\/fimmu.2021.636568","journal-title":"Front Immunol"},{"key":"496_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","volume":"18","author":"Y Duan","year":"2025","unstructured":"Duan Y, Xu Y, Dou Y, Xu D (2025) Helicobacter pylori and gastric cancer: mechanisms and new perspectives. J Hematol Oncol J Hematol Oncol 18:10. https:\/\/doi.org\/10.1186\/s13045-024-01654-2","journal-title":"J Hematol Oncol J Hematol Oncol"},{"key":"496_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/2326-6066.CIR-14-0209","volume":"3","author":"HF Dvorak","year":"2015","unstructured":"Dvorak HF (2015) Tumors: wounds that do not heal\u2014redux. Cancer Immunol Res 3:1\u201311. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0209","journal-title":"Cancer Immunol Res"},{"key":"496_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-9650-1","volume-title":"Essential Readings in Biosemiotics, Biosemiotics","author":"D Favareau","year":"2009","unstructured":"Favareau D (2009) Essential Readings in Biosemiotics, Biosemiotics. Springer Netherlands, Dordrecht. https:\/\/doi.org\/10.1007\/978-1-4020-9650-1"},{"key":"496_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bjc\/azad022","volume":"64","author":"M Fiddler","year":"2024","unstructured":"Fiddler M, Linnemann T, Kindynis T (2024) Ghost criminology: a framework for the discipline\u2019s spectral turn. Br J Criminol 64:1\u201316. https:\/\/doi.org\/10.1093\/bjc\/azad022","journal-title":"Br J Criminol"},{"key":"496_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12967-020-02376-y","volume":"18","author":"A Hauge","year":"2020","unstructured":"Hauge A, Rofstad EK (2020) Antifibrotic therapy to normalize the tumor microenvironment. J Transl Med 18:207. https:\/\/doi.org\/10.1186\/s12967-020-02376-y","journal-title":"J Transl Med"},{"key":"496_CR29","volume-title":"Biosemiotics: an examination into the signs of life and the life of signs, Approaches to postmodernity","author":"J Hoffmeyer","year":"2008","unstructured":"Hoffmeyer J (2008) Biosemiotics: an examination into the signs of life and the life of signs, Approaches to postmodernity. University of Scranton, Scranton, Pa"},{"key":"496_CR30","doi-asserted-by":"publisher","first-page":"19659","DOI":"10.1073\/pnas.0905137106","volume":"106","author":"RD Holt","year":"2009","unstructured":"Holt RD (2009) Bringing the Hutchinsonian niche into the 21st century: Ecological and evolutionary perspectives. Proc Natl Acad Sci 106:19659\u201319665. https:\/\/doi.org\/10.1073\/pnas.0905137106","journal-title":"Proc Natl Acad Sci"},{"key":"496_CR31","doi-asserted-by":"publisher","first-page":"e155148","DOI":"10.1172\/JCI155148","volume":"132","author":"LA Horn","year":"2022","unstructured":"Horn LA, Chariou PL, Gameiro SR, Qin H, Iida M, Fousek K, Meyer TJ, Cam M, Flies D, Langermann S, Schlom J, Palena C (2022) Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-\u03b2 signaling enables PD-L1\u2013mediated tumor eradication. J Clin Invest 132:e155148. https:\/\/doi.org\/10.1172\/JCI155148","journal-title":"J Clin Invest"},{"key":"496_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","volume":"18","author":"Q Hu","year":"2025","unstructured":"Hu Q, Zhu Y, Mei J, Liu Y, Zhou G (2025) Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy. J Hematol Oncol J Hematol Oncol 18:65. https:\/\/doi.org\/10.1186\/s13045-025-01717-y","journal-title":"J Hematol Oncol J Hematol Oncol"},{"key":"496_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02178","author":"Y Hua","year":"2019","unstructured":"Hua Y, Bergers G (2019) Tumors vs. Chronic Wounds: An Immune Cell\u2019s Perspective. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.02178","journal-title":"Front Immunol"},{"key":"496_CR36","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1200\/JCO.2011.36.2335","volume":"29","author":"Y-T Huang","year":"2011","unstructured":"Huang Y-T, Jen C-L, Yang H-I, Lee M-H, Su J, Lu S-N, Iloeje UH, Chen C-J (2011) Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J. Clin. Oncol. Off J Am Soc Clin Oncol 29:3643\u20133650. https:\/\/doi.org\/10.1200\/JCO.2011.36.2335","journal-title":"Off J Am Soc Clin Oncol"},{"key":"496_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, Qiao Y (2021) Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther 6:153. https:\/\/doi.org\/10.1038\/s41392-021-00544-0","journal-title":"Signal Transduct Target Ther"},{"key":"496_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3892\/or.2024.8796","volume":"52","author":"S Huang","year":"2024","unstructured":"Huang S, Qin Z, Wang F, Kang Y, Ren B (2024) A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review). Oncol Rep 52:137. https:\/\/doi.org\/10.3892\/or.2024.8796","journal-title":"Oncol Rep"},{"key":"496_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.37349\/etat.2024.00212","volume":"5","author":"E Jou","year":"2024","unstructured":"Jou E, Chaudhury N, Nasim F (2024) Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment. Explor Target Anti-Tumor Ther 5:187\u2013207. https:\/\/doi.org\/10.37349\/etat.2024.00212","journal-title":"Explor Target Anti-Tumor Ther"},{"key":"496_CR38","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","volume":"153","author":"F Kanwal","year":"2017","unstructured":"Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB (2017) Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology 153:996\u20131005e1. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.012","journal-title":"Gastroenterology"},{"key":"496_CR39","doi-asserted-by":"publisher","first-page":"217432","DOI":"10.1016\/j.canlet.2024.217432","volume":"611","author":"S Kong","year":"2025","unstructured":"Kong S, Zhang J, Wang L, Li W, Guo H, Weng Q, He Q, Lou H, Ding L, Yang B (2025) Mechanisms of low MHC I expression and strategies for targeting MHC I with small molecules in cancer immunotherapy. Cancer Lett 611:217432. https:\/\/doi.org\/10.1016\/j.canlet.2024.217432","journal-title":"Cancer Lett"},{"key":"496_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-031-46917-6_2","volume-title":"New Mechanism, History, Philosophy and Theory of the Life Sciences","author":"B Krickel","year":"2024","unstructured":"Krickel B (2024) Different Types of Mechanistic Explanation and Their Ontological Implications. In: Cordovil JL, Santos G, Vecchi D (eds) New Mechanism, History, Philosophy and Theory of the Life Sciences. Springer International Publishing, Cham, pp 9\u201328. https:\/\/doi.org\/10.1007\/978-3-031-46917-6_2"},{"key":"496_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1515\/semi.1999.127.1-4.385","volume":"127","author":"K Kull","year":"1999","unstructured":"Kull K (1999) Biosemiotics in the twentieth century: A view from biology. semi 127:385\u2013414. https:\/\/doi.org\/10.1515\/semi.1999.127.1-4.385","journal-title":"semi"},{"key":"496_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40364-025-00757-3","volume":"13","author":"JJ Lee","year":"2025","unstructured":"Lee JJ, Ng KY, Bakhtiar A (2025) Extracellular matrix: unlocking new avenues in cancer treatment. Biomark Res 13:78. https:\/\/doi.org\/10.1186\/s40364-025-00757-3","journal-title":"Biomark Res"},{"key":"496_CR43","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/1878-0261.13600","volume":"18","author":"L Li","year":"2024","unstructured":"Li L, He K, Zhou T, Xu Y, Pang J, Yu Q, Gao Y, Shi H, Zhu H, Li M, Yu J, Yuan S (2024) Recurrence\/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA \/ N2 NSCLC. Mol Oncol 18:1649\u20131664. https:\/\/doi.org\/10.1002\/1878-0261.13600","journal-title":"Mol Oncol"},{"key":"496_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/392759","volume":"67","author":"P Machamer","year":"2000","unstructured":"Machamer P, Darden L, Craver CF (2000) Thinking about Mechanisms. Philos Sci 67:1\u201325. https:\/\/doi.org\/10.1086\/392759","journal-title":"Philos Sci"},{"key":"496_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00051","author":"ML Mancini","year":"2014","unstructured":"Mancini ML, Sonis ST (2014) Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2014.00051","journal-title":"Front Pharmacol"},{"key":"496_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/science.1214935","author":"R Medzhitov","year":"2012","unstructured":"Medzhitov R, Schneider DS, Soares MP (2012) Disease tolerance as a defense strategy. Science. https:\/\/doi.org\/10.1126\/science.1214935","journal-title":"Science"},{"key":"496_CR47","doi-asserted-by":"publisher","first-page":"e58688","DOI":"10.7554\/eLife.58688","volume":"10","author":"A Nicolas-Boluda","year":"2021","unstructured":"Nicolas-Boluda A, Vaquero J, Vimeux L, Guilbert T, Barrin S, Kantari-Mimoun C, Ponzo M, Renault G, Deptula P, Pogoda K, Bucki R, Cascone I, Courty J, Fouassier L, Gazeau F, Donnadieu E (2021) Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. eLife 10:e58688. https:\/\/doi.org\/10.7554\/eLife.58688","journal-title":"eLife"},{"key":"496_CR48","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS (2020) Human papillomavirus and cervical cancer. J Obstet Gynaecol 40:602\u2013608. https:\/\/doi.org\/10.1080\/01443615.2019.1634030","journal-title":"J Obstet Gynaecol"},{"key":"496_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","volume":"547","author":"PA Ott","year":"2017","unstructured":"Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, Zhang W, Luoma A, Giobbie-Hurder A, Peter L, Chen C, Olive O, Carter TA, Li S, Lieb DJ, Eisenhaure T, Gjini E, Stevens J, Lane WJ, Javeri I, Nellaiappan K, Salazar AM, Daley H, Seaman M, Buchbinder EI, Yoon CH, Harden M, Lennon N, Gabriel S, Rodig SJ, Barouch DH, Aster JC, Getz G, Wucherpfennig K, Neuberg D, Ritz J, Lander ES, Fritsch EF, Hacohen N, Wu CJ (2017) An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547:217\u2013221. https:\/\/doi.org\/10.1038\/nature22991","journal-title":"Nature"},{"key":"496_CR50","volume-title":"Collected Papers of Charles Sanders Peirce","author":"C Peirce","year":"1934","unstructured":"Peirce C (1934) Collected Papers of Charles Sanders Peirce. Harvard University Press"},{"key":"496_CR51","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3390\/cancers13112635","volume":"13","author":"AS Pierik","year":"2021","unstructured":"Pierik AS, Leemans CR, Brakenhoff RH (2021) Resection margins in head and neck cancer surgery: an update of residual disease and field cancerization. Cancers 13:2635. https:\/\/doi.org\/10.3390\/cancers13112635","journal-title":"Cancers"},{"key":"496_CR52","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/leu.2008.354","volume":"23","author":"A Poggi","year":"2009","unstructured":"Poggi A, Catellani S, Garuti A, Pierri I, Gobbi M, Zocchi MR (2009) Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. Leukemia 23:641\u2013648. https:\/\/doi.org\/10.1038\/leu.2008.354","journal-title":"Leukemia"},{"key":"496_CR53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","volume":"222","author":"PC Rodr\u00edguez","year":"2008","unstructured":"Rodr\u00edguez PC, Ochoa AC (2008) Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 222:180\u2013191. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00608.x","journal-title":"Immunol Rev"},{"key":"496_CR54","first-page":"195","volume":"26","author":"SB Rosenthal","year":"1990","unstructured":"Rosenthal SB (1990) Peirce\u2019s ultimate logical interpretant and dynamical object: a pragmatic perspective. Trans Charles Peirce Soc 26:195\u2013210","journal-title":"Trans Charles Peirce Soc"},{"key":"496_CR55","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","volume":"547","author":"U Sahin","year":"2017","unstructured":"Sahin U, Derhovanessian E, Miller M, Kloke B-P, Simon P, L\u00f6wer M, Bukur V, Tadmor AD, Luxemburger U, Schr\u00f6rs B, Omokoko T, Vormehr M, Albrecht C, Paruzynski A, Kuhn AN, Buck J, Heesch S, Schreeb KH, M\u00fcller F, Ortseifer I, Vogler I, Godehardt E, Attig S, Rae R, Breitkreuz A, Tolliver C, Suchan M, Martic G, Hohberger A, Sorn P, Diekmann J, Ciesla J, Waksmann O, Br\u00fcck A-K, Witt M, Zillgen M, Rothermel A, Kasemann B, Langer D, Bolte S, Diken M, Kreiter S, Nemecek R, Gebhardt C, Grabbe S, H\u00f6ller C, Utikal J, Huber C, Loquai C, T\u00fcreci \u00d6 (2017) Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547:222\u2013226. https:\/\/doi.org\/10.1038\/nature23003","journal-title":"Nature"},{"key":"496_CR56","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3389\/fimmu.2018.02040","volume":"9","author":"D Schmiedel","year":"2018","unstructured":"Schmiedel D, Mandelboim O (2018) NKG2D ligands\u2013critical targets for cancer immune escape and therapy. Front Immunol 9:2040. https:\/\/doi.org\/10.3389\/fimmu.2018.02040","journal-title":"Front Immunol"},{"key":"496_CR57","doi-asserted-by":"publisher","first-page":"101312","DOI":"10.1016\/j.tranon.2021.101312","volume":"16","author":"G Shanmugam","year":"2022","unstructured":"Shanmugam G, Rakshit S, Sarkar K (2022) HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases. Transl Oncol 16:101312. https:\/\/doi.org\/10.1016\/j.tranon.2021.101312","journal-title":"Transl Oncol"},{"key":"496_CR58","first-page":"89","volume":"79","author":"D Slaughter","year":"1944","unstructured":"Slaughter D (1944) The multiplicity of origin of malignant tumors: collective review. Int Abstr Surg 79:89\u201398","journal-title":"Int Abstr Surg"},{"key":"496_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195309)6","author":"DP Slaughter","year":"1953","unstructured":"Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer https:\/\/doi.org\/10.1002\/1097-0142(195309)6","journal-title":"Cancer"},{"key":"496_CR60","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu K, Tavel JA (2010) What are biomarkers? Curr. Opin HIV AIDS 5:463\u2013466. https:\/\/doi.org\/10.1097\/COH.0b013e32833ed177","journal-title":"Opin HIV AIDS"},{"key":"496_CR61","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.7150\/jca.34471","volume":"10","author":"T Sun","year":"2019","unstructured":"Sun T, Li Y, Yang W, Wu H, Li X, Huang Y, Zhou Y, Du Z (2019) Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells. J Cancer 10:5638\u20135645. https:\/\/doi.org\/10.7150\/jca.34471","journal-title":"J Cancer"},{"key":"496_CR62","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun X, Wu B, Chiang H-C, Deng H, Zhang X, Xiong W, Liu J, Rozeboom AM, Harris BT, Blommaert E, Gomez A, Garcia RE, Zhou Y, Mitra P, Prevost M, Zhang D, Banik D, Isaacs C, Berry D, Lai C, Chaldekas K, Latham PS, Brantner CA, Popratiloff A, Jin VX, Zhang N, Hu Y, Pujana MA, Curiel TJ, An Z, Li R (2021) Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599:673\u2013678. https:\/\/doi.org\/10.1038\/s41586-021-04057-2","journal-title":"Nature"},{"key":"496_CR63","first-page":"1523","volume":"7","author":"MP Tabor","year":"2001","unstructured":"Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, Snow GB, Leemans CR, Braakhuis BJ (2001) Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res Off J Am Assoc Cancer Res 7:1523\u20131532","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"496_CR64","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/biology12081079","volume":"12","author":"G Tan","year":"2023","unstructured":"Tan G, Spillane KM, Maher J (2023) The role and regulation of the NKG2D\/NKG2D ligand system in cancer. Biology 12:1079. https:\/\/doi.org\/10.3390\/biology12081079","journal-title":"Biology"},{"key":"496_CR65","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","volume":"8","author":"DA Thomas","year":"2005","unstructured":"Thomas DA, Massagu\u00e9 J (2005) TGF-\u03b2 directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8:369\u2013380. https:\/\/doi.org\/10.1016\/j.ccr.2005.10.012","journal-title":"Cancer Cell"},{"key":"496_CR66","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev-immunol-020711-075008","volume":"30","author":"G Trinchieri","year":"2012","unstructured":"Trinchieri G (2012) Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts. Annu Rev Immunol 30:677\u2013706. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075008","journal-title":"Annu Rev Immunol"},{"key":"496_CR67","doi-asserted-by":"publisher","first-page":"e26097","DOI":"10.4161\/onci.26097","volume":"2","author":"E Ullrich","year":"2013","unstructured":"Ullrich E, Koch J, Cerwenka A, Steinle A (2013) New prospects on the NKG2D\/NKG2DL system for oncology. Oncoimmunology 2:e26097. https:\/\/doi.org\/10.4161\/onci.26097","journal-title":"Oncoimmunology"},{"key":"496_CR68","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1042\/CS20201236","volume":"135","author":"J Van Den Bulk","year":"2021","unstructured":"Van Den Bulk J, De Miranda NFCC, Ten Dijke P (2021) Therapeutic targeting of TGF-\u03b2 in cancer: hacking a master switch of immune suppression. Clin Sci 135:35\u201352. https:\/\/doi.org\/10.1042\/CS20201236","journal-title":"Clin Sci"},{"key":"496_CR69","unstructured":"Virchow R (1858) Die Cellularpathologie in ihrer Begr\u00fcndung auf physiologische and pathologische Gewebelehre. Verl. Von August Hirschfeld Berl."},{"key":"496_CR71","doi-asserted-by":"publisher","DOI":"10.1515\/semi.1992.89.4.319","author":"J von Uexk\u00fcll","year":"1992","unstructured":"von Uexk\u00fcll J (1992) A stroll through the worlds of animals and men: a picture book of invisible worlds. Semiotica. https:\/\/doi.org\/10.1515\/semi.1992.89.4.319.\u00a0","journal-title":"Semiotica"},{"key":"496_CR70","volume-title":"A foray into the worlds of animals and humans: with A theory of meaning, 1st University of Minnesota Press ed. ed, Posthumanities","author":"J von Uexk\u00fcll","year":"2010","unstructured":"von Uexk\u00fcll J (2010) A foray into the worlds of animals and humans: with A theory of meaning, 1st University of Minnesota Press ed. ed, Posthumanities. University of Minnesota Press, Minneapolis"},{"key":"496_CR72","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/0969725X.2023.2270356","volume":"28","author":"J Walklate","year":"2023","unstructured":"Walklate J (2023) Forgettings That Want to be Remembered: museums and hauntings. Angelaki 28:71\u201383. https:\/\/doi.org\/10.1080\/0969725X.2023.2270356","journal-title":"Angelaki"},{"key":"496_CR73","doi-asserted-by":"publisher","first-page":"2455539","DOI":"10.1080\/07853890.2025.2455539","volume":"57","author":"J Wang","year":"2025","unstructured":"Wang J, Qiu K, Zhou S, Gan Y, Jiang K, Wang D, Wang H (2025) Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis. Ann Med 57:2455539. https:\/\/doi.org\/10.1080\/07853890.2025.2455539","journal-title":"Ann Med"},{"key":"496_CR74","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski LE, Peek RM, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23:713\u2013739. https:\/\/doi.org\/10.1128\/CMR.00011-10","journal-title":"Clin Microbiol Rev"},{"key":"496_CR75","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","volume":"22","author":"X Wu","year":"2023","unstructured":"Wu X, Li T, Jiang R, Yang X, Guo H, Yang R (2023) Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. Mol Cancer 22:194. https:\/\/doi.org\/10.1186\/s12943-023-01899-4","journal-title":"Mol Cancer"}],"container-title":["Theory in Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12064-026-00496-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12064-026-00496-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12064-026-00496-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:11:04Z","timestamp":1792152664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12064-026-00496-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1007\/s12064-026-00496-5","relation":{},"ISSN":["1431-7613","1611-7530"],"issn-type":[{"value":"1431-7613","type":"print"},{"value":"1611-7530","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"47"}}